The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

Matthew R. Cooperberg, Peter R. Carroll, Marc A. Dall'Era, Benjamin J. Davies, John W. Davis, Scott E. Eggener, Felix Y. Feng, Daniel W. Lin, Todd M. Morgan, Alicia K. Morgans, Daniel E. Spratt, Samir S. Taneja, David F. Penson

    Research output: Contribution to journalEditorial

    Abstract

    We convened a multidisciplinary expert panel to make recommendations on current utility and future research needs for post-diagnosis prostate cancer biomarkers. The San Francisco Consensus Statement reflects on the rapid recent progress achieved, and the substantial work still ahead.

    Original languageEnglish (US)
    Pages (from-to)268-272
    Number of pages5
    JournalEuropean Urology
    Volume76
    Issue number3
    DOIs
    StatePublished - Sep 2019

    ASJC Scopus subject areas

    • Urology

    Fingerprint Dive into the research topics of 'The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement'. Together they form a unique fingerprint.

  • Cite this

    Cooperberg, M. R., Carroll, P. R., Dall'Era, M. A., Davies, B. J., Davis, J. W., Eggener, S. E., Feng, F. Y., Lin, D. W., Morgan, T. M., Morgans, A. K., Spratt, D. E., Taneja, S. S., & Penson, D. F. (2019). The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement. European Urology, 76(3), 268-272. https://doi.org/10.1016/j.eururo.2019.05.013